Cargando...
Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury
Sepsis-associated acute kidney injury (SA-AKI) is associated with high mortality rates, but clinicians lack effective treatments except supportive care or renal replacement therapies. Recently, histone deacetylase (HDAC) inhibitors have been recognized as potential treatments for acute kidney injury...
Gardado en:
| Publicado en: | Am J Physiol Renal Physiol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Physiological Society
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792695/ https://ncbi.nlm.nih.gov/pubmed/33017186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00405.2020 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|